F45.41
Conditions
Interventions
Group 1: The translated version of the CEQ will be presented to the patients at two separate times during the study: t1) before the patients start the therapy program, but after they have been informe
t2) one week after the beginning of the treatment program. For the purpose of investigating the convergent, incremental and discriminant validity of the CEQ, the patients are also asked to fill out th
Schulte, 2005) as well as a questionnaire measuring their overall expectation of self-efficacy (SWE, Schwarzer & Jerusalem, 1988) at both t1 and t2. In order to test the predictive validity of the CEQ
Sponsors
Universitätsklinikum Carl Gustav Carus, UniversitätsSchmerzCentrum (USC)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients who suffer from chronic, non-tumor-related pain and are taking part in an interdisciplinary pain therapy in one of two cooperating institutions (UniversitätsSchmerzCentrum Dresden, Rückenschmerz-Zentrum Essen) will be included in the study.
Exclusion criteria
Exclusion criteria: Exclusion criteria are tumor-related pain, age under 18 years, a lack of a certain physical or psychological stability required for the treatment program (tested within medical, psychological and physiotherapeutic assessments), or severe psychiatric disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - translated version of the CEQ at t1 (before the patients start the therapy program) and t2 (one week after the beginning of the treatment program) | — |
Secondary
| Measure | Time frame |
|---|---|
| - questionnaire about treatment expectations and therapy evaluation (PATHEV; Schulte, 2005) at both t1 and t2 - questionnaire assessing their overall expectation of self-efficacy (SWE, Schwarzer & Jerusalem, 1988) at both t1 and t2 - the German version of the "Pain catastrophizing scale" (Meyer, Sprott & Mannion, 2008) at t1, t3 (the end of the therapy) and t4 (10 weeks after the end of the treatment) - the German version of the "Chronic Pain Acceptance Questionnaire (CPAQ-D)" (Nilges, Köster & Schmidt, 2007) at t1, t3 and t4 - the "Pain Disability Index (PDI)" (Dillmann, Nilges, Saile & Gerbershagen, 1994) at t1, t3 and t4 - the SF-12 as a short form of the SF-36 (Bullinger, 2000), whereby only the scale "overall perception of health" will be used at t1, t3 and t4 - overall evaluation of treatment success on a 5-point rating scale (very good - bad) at t3 and t4 (Deutscher Schmerzfragebogen der DGSS, web-link: http://www.dgss.org/deutscher-Schmerzfragebogen/) | — |
Countries
Germany
Contacts
Public ContactLisa Burdic
Universitätsklinikum Carl Gustav Carus,UniversitätsSchmerzCentrum (USC)
Outcome results
None listed